Transportation and retention in outpatient drug abuse treatment programs

被引:49
作者
Friedmann, PD
Lemon, SC
Stein, MD
机构
[1] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med,Div Gen Internal Med, Providence, RI 02903 USA
[2] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Community Hlth, Providence, RI 02903 USA
关键词
transportation of patients; patient dropouts; substance-related disorders; methadone; substance abuse treatment centers; health services accessibility;
D O I
10.1016/S0740-5472(01)00185-4
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
To determine whether certain types of transportation assistance improve outpatient treatment retention beyond thresholds shown to have therapeutic benefits, we analyzed data from 1,144 clients in 22 outpatient methadone maintenance (OM-NI) programs and 2,031 clients in 22 outpatient drug-free (ODF) programs in the Drug Abuse Treatment Outcomes Study (DATOS), a national, 12-month, longitudinal study of drug abuse treatment programs. Directors' surveys provided information about provision of car, van, or contracted transportation services or individual vouchers/payment for public transportation. Chart-abstracted treatment retention was dichotomized at 365 days for OMM and 90 days for ODF. Separate multivariate hierarchical linear models revealed that provision of car, van, or contracted transportation services improved treatment retention beyond these thresholds for both OMM and ODF, but individual vouchers or payment for public transportation did not. Future research should validate whether car, van, or contracted transportation services improve retention and other treatment outcomes in outpatient drug abuse treatment. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 25 条
[1]   INTERVIEWER SEVERITY RATINGS AND COMPOSITE SCORES OF THE ASI - A FURTHER LOOK [J].
ALTERMAN, AI ;
BROWN, LS ;
ZABALLERO, A ;
MCKAY, JR .
DRUG AND ALCOHOL DEPENDENCE, 1994, 34 (03) :201-209
[2]   REVISITING THE BEHAVIORAL-MODEL AND ACCESS TO MEDICAL-CARE - DOES IT MATTER [J].
ANDERSEN, RM .
JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 1995, 36 (01) :1-10
[3]  
[Anonymous], 1982, Advances in Alcohol and Substance Abuse
[4]  
[Anonymous], 1989, Drug abuse treatment: A national study of effectiveness
[5]  
*ASAM WORK GROUP P, 1996, ASAM PAT PLAC CRIT S
[6]   Interferon-α protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes [J].
Brooks, TJG ;
Phillpotts, RJ .
ANTIVIRAL RESEARCH, 1999, 41 (01) :57-64
[7]  
Bryk A.S., 1992, Hierarchical Models: Applications and Data Analysis Methods
[8]   Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS) [J].
Flynn, PM ;
Craddock, SG ;
Hubbard, RL ;
Anderson, J ;
Etheridge, RM .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 1997, 11 (04) :230-243
[9]   Linkage to medical services in the drug abuse treatment outcome study [J].
Friedmann, PD ;
Lemon, SC ;
Stein, MD ;
Etheridge, RM ;
D'Aunno, TA .
MEDICAL CARE, 2001, 39 (03) :284-295
[10]  
Guidry JJ, 1997, CANCER PRACT, V5, P361